Atreca (BCEL) Prices 7.031 Class A Share Common Offering at $16/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- S&P 500 up, Nasdaq at record high as megacap tech stocks rise
- Oil slips on rise in Middle East crude exports and G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
- Alaska LNG shipping savings justifies billions in investment, developer says
- Citi cuts investment banking analyst program to two years - Bloomberg
- S&P 500 up, Nasdaq at record high as megacap tech stocks rise
- Paramount Skydance to close WBD deal, change ticker to SKYD
- This multi-trillion stock is "cheap and getting cheaper": Morgan Stanley
Atreca (BCEL) Plans Underwritten Public Offering of Class A Common Stock
July 15, 2020 4:02 PM EDTAtreca, Inc. (Nasdaq: BCEL), a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types, today announced that it intends to offer shares of its Class A Common Stock (the Shares) in an underwritten... More



